Xiangya Hospital of Central South University
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Su, Juan
NCT05793892: Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults

Completed
3
286
RoW
Lidocaine tetracaine cream, test drug:CU-30101, control drug:Pliaglis
Cutia Therapeutics(Wuxi)Co.,Ltd
Analgesia
08/23
10/23
NCT05470413: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Active, not recruiting
3
330
RoW
SHR0302, Placebo
Reistone Biopharma Company Limited
Alopecia Areata
10/23
02/24
NCT06477237: Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting
3
400
RoW
HB0017 Q4W, HB0017 Q8W, placebo
Huabo Biopharm Co., Ltd.
Psoriasis
08/24
12/25
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis

Recruiting
3
552
RoW
ICP-332 Tablets, ICP-332 Placebo Tablets
Beijing InnoCare Pharma Tech Co., Ltd.
Atopic Dermatitis
11/26
12/26
NCT05531682: A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Completed
2
160
RoW
Placebo, HB0017, HB0017 dosing regimens
Huabo Biopharm Co., Ltd.
Plaque Psoriasis
05/23
01/24
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting
2
129
RoW
ICP-488 Tablets, ICP-488 Placebo
Beijing InnoCare Pharma Tech Co., Ltd.
Moderate to Severe Plaque Psoriasis
10/24
11/24
NCT06802848: Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Not yet recruiting
N/A
1000
RoW
Xeligekimab injection
Chongqing Genrix Biopharmaceutical Co., Ltd, Xiangya Hospital of Central South University
Plaque Psoriasis, Psoriatic Arthritis, Scalp Psoriasis, Nail Psoriasis, Palmoplantar Psoriasis, Genital Psoriasis
03/26
12/26
NCT04465838: Chinese Psoriasis Real World Evidence Research

Recruiting
N/A
10000
RoW
NIS
Second Affiliated Hospital, School of Medicine, Zhejiang University
Psoriasis
07/30
07/30
Cao, Lanqin
No trials found

Download Options